Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1081.15
(2.68%)
INR 1081.15
(2.68%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.31 Billion INR | -26.09% |
| 2022 | 3.12 Billion INR | 10.37% |
| 2021 | 2.83 Billion INR | 40.95% |
| 2020 | 2.01 Billion INR | 14.99% |
| 2019 | 1.74 Billion INR | 11.31% |
| 2018 | 1.57 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 2.71 Billion INR | 0.0% |
| 2023 FY | 2.31 Billion INR | -26.09% |
| 2023 Q3 | 2.53 Billion INR | -6.73% |
| 2023 Q4 | 2.31 Billion INR | -8.69% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 3.12 Billion INR | 10.37% |
| 2022 Q4 | 3.12 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 3.18 Billion INR | 0.0% |
| 2021 Q4 | 2.83 Billion INR | 0.0% |
| 2021 FY | 2.83 Billion INR | 40.95% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 2.64 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 2.01 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 2.01 Billion INR | 14.99% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 1.97 Billion INR | 0.0% |
| 2019 Q4 | 1.74 Billion INR | 0.0% |
| 2019 FY | 1.74 Billion INR | 11.31% |
| 2019 Q1 | - INR | -100.0% |
| 2018 FY | 1.57 Billion INR | 0.0% |
| 2018 Q4 | 1.57 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 85.933% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 97.643% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 65.317% |
| Granules India Limited | 13 Billion INR | 82.223% |
| Indoco Remedies Limited | 3.53 Billion INR | 34.517% |
| Achyut Healthcare Limited | 568 Thousand INR | -406934.683% |
| Ajanta Pharma Limited | 8.28 Billion INR | 72.09% |
| Alkem Laboratories Limited | 26.61 Billion INR | 91.312% |
| Alpa Laboratories Limited | 136.65 Million INR | -1591.845% |
| Brooks Laboratories Limited | 96.1 Million INR | -2305.582% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -1.454% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -60.51% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -95.189% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 96.362% |
| Eris Lifesciences Limited | 1.89 Billion INR | -22.305% |
| FDC Limited | 3.88 Billion INR | 40.55% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 90.8% |
| Gufic Biosciences Limited | 2 Billion INR | -15.32% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -2110.77% |
| Ipca Laboratories Limited | 24.71 Billion INR | 90.645% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -1441.613% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -2260.007% |
| Lasa Supergenerics Limited | 190.43 Million INR | -1114.046% |
| Laurus Labs Limited | 18.45 Billion INR | 87.472% |
| Lupin Limited | 49.53 Billion INR | 95.333% |
| Mankind Pharma Limited | 15.53 Billion INR | 85.117% |
| Medicamen Biotech Limited | 593.75 Million INR | -289.381% |
| Medico Remedies Limited | 163.37 Million INR | -1315.149% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 66.996% |
| Piramal Pharma Limited | 21.75 Billion INR | 89.375% |
| RPG Life Sciences Limited | 1.01 Billion INR | -128.907% |
| Sigachi Industries Limited | 707.2 Million INR | -226.914% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 97.657% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -996.676% |
| Unichem Laboratories Limited | 7.04 Billion INR | 67.191% |
| Wanbury Limited | 360.23 Million INR | -541.797% |
| Windlas Biotech Limited | 621.89 Million INR | -271.763% |
| ZIM Laboratories Limited | 812.62 Million INR | -184.503% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 93.283% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 92.739% |
| Hester Biosciences Limited | 755.81 Million INR | -205.891% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -111.892% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -699.855% |
| Bal Pharma Limited | 878.11 Million INR | -163.287% |
| Strides Pharma Science Limited | 11.26 Billion INR | 79.472% |
| Venus Remedies Limited | 1.21 Billion INR | -89.987% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 64.036% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 67.398% |
| Shilpa Medicare Limited | 3.44 Billion INR | 32.973% |
| Aarti Drugs Limited | 4.85 Billion INR | 52.418% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 45.581% |
| Suven Life Sciences Limited | 7.08 Million INR | -32531.715% |
| Ind-Swift Limited | 640.91 Million INR | -260.728% |
| Valiant Laboratories Limited | 100.15 Million INR | -2208.402% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 53.992% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 35.725% |
| Themis Medicare Limited | 705.74 Million INR | -227.592% |
| Hikal Limited | 3.03 Billion INR | 23.879% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 89.855% |
| Sequent Scientific Limited | 3.46 Billion INR | 33.225% |
| Novartis India Limited | 448.6 Million INR | -415.372% |
| Wockhardt Limited | 6.4 Billion INR | 63.876% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 82.072% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -8967.565% |
| Neuland Laboratories Limited | 3.5 Billion INR | 34.024% |
| Morepen Laboratories Limited | 2.48 Billion INR | 6.999% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -5697.284% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -86.991% |